CL has been shown to improve obesity-associated insulin resistance in other models, and we have shown this compound to be sufficient to rescue metabolic dysfunction in ERα null mice, a model of metabolic dysfunction due to loss of E2 signaling (Clookey et al., 2019). The gene discussed is ESR1; the disease is Insulin resistance.